FDA approves gene therapy for MPS IIIA

• by Kathryn Wighton

• September 18, 2026

FDA approves first therapy for Alexander disease

The antisense oligonucleotide reduces production of the abnormal protein that accumulates in supportive cells in the brain.

• by Kathryn Wighton

• September 4, 2026

• 2 min

Educators weigh how to use AI without losing critical thinking

Greater productivity is not necessarily indicative of greater knowledge.

• by Julia Cipriano, MS, CMPP

• September 10, 2026

• 8 min

Marked Increase in Diabetic Ketoacidosis Rates With Modest Increase in HbA1c Elevation at Diabetes Diagnosis in Swedish Children

• by Frida Sundberg, Katarina Eeg-Olofsson, Karin Åkesson

• September 17, 2026